Grannus Therapeutics

Biotechnology
$950klatest round · Venture round · Jan 2022 · 4 yr ago
3backers · Plug and Play, 1842 Fund & Studio
$580kgrants · 2 grants · CORDIS
10+team · employees, estimated range

Overview

Meet the Grannus leadership team—biotech veterans and oncology innovators united by a mission to deliver smarter, safer, and more effective targeted cancer treatments.

Funding and backers

Total raised
$950k
4 rounds on record
Latest round
$950k
Venture round · Jan 2022 · 4 yr ago
Team
11-50
employees, estimated range
Grants
$580k
2 grants · CORDIS
Backers
3
Plug and Play, 1842 Fund & Studio
The money's age
Long since its last round
57 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 17, 2023 Took on debt financing $800k · SEC Form D Jan 12, 2022 Raised a round Venture round $950k · SEC Form D Sep 1, 2021 Won a grant $347k · CORDIS Aug 1, 2020 Won a grant $233k · CORDIS 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing Nov 2023 $800k — SEC Form D
Venture round Jan 2022 $950k — SEC Form D
Grant Sep 2021 $347k — CORDIS
Grant Aug 2020 $233k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity Grannus Therapeutics Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
John FoglesongExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Plug and Play accelerator 1842 Fund & Studio fund Elevate Ventures fund
Investors in similar startupsfunds that back the companies most like this one
Parkwalk Advisors
backs Entia
BGF
backs Entia
Bayern Kapital
backs Nuclidium
Oxford Technology
backs Entia
Imperial College London
backs Entia
M Ventures
backs Kivu Bioscience
Similar startupsby what they do, their industry and backers
Cairn TherapeuticsVenture round $3M · 5 yr ago · Founded 2020 · 51-200 employees
Cairn Therapeutics: Targeting the Cancer, just the cancer. Making cancer treatment simpler and safer with CT-262.
NuclidiumSeries B · 5 mo ago · 51-200 employees
Setting a New Standard in Precision Oncology. Next-generation copper-based radiopharmaceuticals enable the highest accuracy and…
EntiaVenture round · 1 mo ago · Founded 2014
Entia is making life better for people receiving cancer treatment.
Valgotech11-50 employees
Valgotech is the leading innovator is battery storage technologies.
Kivu BioscienceSeries A $92M · 2 yr ago · 1-10 employees
At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer…
Trinity GuardionVenture round $218k · 9 mo ago · 1-10 employees
SAFER BED SAFER PATIENT RE-ENGINEERINGPATIENT SAFETY.FROM OVERLOOKEDTO ACCOUNTABLE. Protect the bed. Control the process. Measure the…

Financials

Total raised
$2.3M
Latest round
Debt Financing
Funding rounds
4
Funding rounds
Round Announced Amount
Debt Financing 2023 $800k Details
Venture - Series Unknown 2022 $950k Details
Grant 2021 $347k Details
Grant 2020 $233k Details

People

John Foglesong
Executive Officer, Director
SEC Form D
James Thompson
Director
SEC Form D
Brian Blagg
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
1842 Fund & StudioVia a fund
9 portfolio companies: NearWave, Amulis, Routora and 6 more
Elevate VenturesVia a fund
325 portfolio companies: Zorion Medical, Fashion Labs, Mykala and 322 more
Plug and PlayVia a fund
2741 portfolio companies
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Indianapolis United States
HQ
10-50 est. staff